Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 2152.HK
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Positive
83%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio 0.00 1.70 1.70
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -190.90 -9.09 -3.12
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value 0.00 7.88 7.88
Cash 3.85 4.80 4.62
Capex 0.00 -0.04 -0.04
Free Cash Flow 0.00 0.63 0.63
Revenue 0.00 1.90 1.90
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin 0.00 0.19 0.19
Operating Margin 0.00 0.12 0.12
ROA 0.00 0.01 0.01
ROE 0.00 0.02 0.02
ROIC 19.93 0.02 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 2152.HK is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 2152.HK is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 2152.HK is permitted for members.